BRT

Burleson Research Technologies is a leading contract research organization specializing in the design, execution, and interpretation of immunotoxicology and immunotoxicity studies. With experience in both in vivo and in vitro assessments, it conducts preclinical trials worldwide to promote a healthy immune system.